Diagnostic Microbiology & Infectious Disease
Volume 66, Issue 3 , Pages 253-260 , March 2010

Sequential changes of Legionella antigens and bacterial load in the lungs and urines of a mouse model of pneumonia

  • Yu Chen

      Affiliations

    • Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo 143-8540, Japan
    • Division of Pulmonary Medicine, Infectious Diseases, and Oncology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan
    • Department of Respiratory Medicine, Shengjing Hospital, China Medical University, Shenyang 110004, China
  • ,
  • Kazuhiro Tateda

      Affiliations

    • Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo 143-8540, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-3-3762-4151x2396; fax: +81-3-5493-5415.
  • ,
  • Kazue Fujita

      Affiliations

    • Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo 143-8540, Japan
    • Division of Pulmonary Medicine, Infectious Diseases, and Oncology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan
  • ,
  • Toshiaki Ishii

      Affiliations

    • Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo 143-8540, Japan
  • ,
  • Yoshikazu Ishii

      Affiliations

    • Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo 143-8540, Japan
  • ,
  • Soichiro Kimura

      Affiliations

    • Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo 143-8540, Japan
  • ,
  • Tomoo Saga

      Affiliations

    • Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo 143-8540, Japan
  • ,
  • Toshimitsu Annaka

      Affiliations

    • Biochemical Research Laboratory, Eiken Chemical Co., Ltd., 143 Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan
  • ,
  • Shingo Yamada

      Affiliations

    • Shino-Test Corporation, Sagamihara-shi, Kanagawaken 229-0011, Japan
  • ,
  • Li Zhao

      Affiliations

    • Department of Respiratory Medicine, Shengjing Hospital, China Medical University, Shenyang 110004, China
  • ,
  • Shengqi Li

      Affiliations

    • Department of Respiratory Medicine, Shengjing Hospital, China Medical University, Shenyang 110004, China
  • ,
  • Arata Azuma

      Affiliations

    • Division of Pulmonary Medicine, Infectious Diseases, and Oncology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan
  • ,
  • Akihiko Gemma

      Affiliations

    • Division of Pulmonary Medicine, Infectious Diseases, and Oncology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan
  • ,
  • Shoji Kudoh

      Affiliations

    • Division of Pulmonary Medicine, Infectious Diseases, and Oncology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan
  • ,
  • Keizo Yamaguchi

      Affiliations

    • Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo 143-8540, Japan

Received 19 August 2009 ,Accepted 3 November 2009.

References 

  1. Alleva LM, Budd AC, Clark IA. Systemic release of high mobility group box 1 protein during severe murine influenza. J. Immunol. 2008;181:1454–1459
  2. Bianchi ME, Manfredi AA. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol. Rev. 2007;220:35–46
  3. Breiman RF, Butler JC. Legionnaires' disease: clinical, epidemiological, and public health perspectives. Semin. Respir. Infect. 1998;13:84–89
  4. Brieland JK, Remick DG, Freeman PT, Hurley MC, Fantone JC, Engleberg NC. In vivo regulation of replicative Legionella pneumophila lung infection by endogenous tumor necrosis factor alpha and nitric oxide. Infect. Immun. 1995;63:3253–3258
  5. Byrne B, Swanson MS. Expression of Legionella pneumophila virulence traits in response to growth conditions. Infect. Immun. 1998;66:3029–3034
  6. Couch RB. The effects of influenza on host defenses. J. Infect. Dis. 1981;144:284–291
  7. Diederen BM. Legionella spp. and Legionnaires' disease. J. Infect. 2008;56:1–12
  8. Dominguez JA, Gali N, Pedroso P, Fargas A, Padilla E, Manterola JM, et al. Comparison of the Binax Legionella urinary antigen enzyme immunoassay (EIA) with the Biotest Legionella Urin antigen EIA for detection of Legionella antigen in both concentrated and nonconcentrated urine samples. J. Clin. Microbiol. 1998;36:2718–2722
  9. el-Ebiary M, Sarmiento X, Torres A, Nogue S, Mesalles E, Bodi M, et al. Prognostic factors of severe Legionella pneumonia requiring admission to ICU. Am. J. Respir. Crit. Care Med. 1997;156:1467–1472
  10. Fernandez-Serrano S, Dorca J, Coromines M, Carratala J, Gudiol F, Manresa F. Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia. Clin. Diagn. Lab. Immunol. 2003;10:813–820
  11. Fields BS, Benson RF, Besser RE. Legionella and Legionnaires' disease: 25 years of investigation. Clin. Microbiol. Rev. 2002;15:506–526
  12. Furugen M, Higa F, Hibiya K, Teruya H, Akamine M, Haranaga S, et al. Legionella pneumophila infection induces programmed cell death, caspase activation, and release of high-mobility group box 1 protein in A549 alveolar epithelial cells: inhibition by methyl prednisolone. Respir. Res. 2008;9:39
  13. Gebran SJ, Newton C, Yamamoto Y, Widen R, Klein TW, Friedman H. Macrophage permissiveness for Legionella pneumophila growth modulated by iron. Infect. Immun. 1994;62:564–568
  14. Grover A, Taylor J, Troudt J, Keyser A, Sommersted K, Schenkel A, et al. Mycobacterial infection induces the secretion of high-mobility group box 1 protein. Cell. Microbiol. 2008;10:1390–1404
  15. Gump DW, Frank RO, Winn WC, Foster RS, Broome CV, Cherry WB. Legionnaires' disease in patients with associated serious disease. Ann. Intern. Med. 1979;90:538–542
  16. Kohler RB, Winn WC, Wheat LJ. Onset and duration of urinary antigen excretion in Legionnaires disease. J. Clin. Microbiol. 1984;20:605–607
  17. Kragsbjerg P, Jones I, Vikerfors T, Holmberg H. Diagnostic value of blood cytokine concentrations in acute pneumonia. Thorax. 1995;50:1253–1257
  18. Le Roux CA, Kubo T, Grobbelaar AA, van Vuren PJ, Weyer J, Nel LH, et al. Development and evaluation of a real-time reverse transcription-loop–mediated isothermal amplification assay for rapid detection of Rift Valley fever virus in clinical specimens. J. Clin. Microbiol. 2009;47:645–651
  19. Lieberman D, Porath A, Schlaeffer F, Boldur I. Legionella species community-acquired pneumonia. A review of 56 hospitalized adult patients. Chest. 1996;109:1243–1249
  20. Marston BJ, Plouffe JF, File TM, Hackman BA, Salstrom SJ, Lipman HB, et al. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch. Intern. Med. 1997;157:1709–1718
  21. Nagamine K, Watanabe K, Ohtsuka K, Hase T, Notomi T. Loop-mediated isothermal amplification reaction using a nondenatured template. Clin. Chem. 2001;47:1742–1743
  22. Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000;28:E63
  23. Parida M, Sannarangaiah S, Dash PK, Rao PV, Morita K. Loop mediated isothermal amplification (LAMP): a new generation of innovative gene amplification technique; perspectives in clinical diagnosis of infectious diseases. Rev. Med. Virol. 2008;18:407–421
  24. Pedro-Botet ML, Sabria-Leal M, Sopena N, Manterola JM, Morera J, Blavia R, et al. Role of immunosuppression in the evolution of Legionnaires' disease. Clin. Infect. Dis. 1998;26:14–19
  25. Plouffe JF, File TM, Breiman RF, Hackman BA, Salstrom SJ, Marston BJ, et al. Reevaluation of the definition of Legionnaires' disease: use of the urinary antigen assay. Community Based Pneumonia Incidence Study Group. Clin. Infect. Dis. 1995;20:1286–1291
  26. Roig J, Sabria M, Pedro-Botet ML. Legionella spp.: community acquired and nosocomial infections. Curr. Opin. Infect. Dis. 2003;16:145–151
  27. Salins S, Newton C, Widen R, Klein TW, Friedman H. Differential induction of gamma interferon in Legionella pneumophila-infected macrophages from BALB/c and A/J mice. Infect. Immun. 2001;69:3605–3610
  28. Skerrett SJ, Bagby GJ, Schmidt RA, Nelson S. Antibody-mediated depletion of tumor necrosis factor-alpha impairs pulmonary host defenses to Legionella pneumophila. J. Infect. Dis. 1997;176:1019–1028
  29. Swartz MN. Clinical aspects of Legionnaires' disease. Ann. Intern. Med. 1979;90:492–495
  30. Tan MJ, Tan JS, File TM. Legionnaires disease with bacteremic coinfection. Clin. Infect. Dis. 2002;35:533–539
  31. Tateda K, Matsumoto T, Ishii Y, Furuya N, Ohno A, Miyazaki S, et al. Serum cytokines in patients with Legionella pneumonia: relative predominance of Th1-type cytokines. Clin. Diagn. Lab. Immunol. 1998;5:401–403
  32. Tateda K, Deng JC, Moore TA, Newstead MW, Paine R, Kobayashi N, et al. Hyperoxia mediates acute lung injury and increased lethality in murine Legionella pneumonia: the role of apoptosis. J. Immunol. 2003;170:4209–4216
  33. Tkatch LS, Kusne S, Irish WD, Krystofiak S, Wing E. Epidemiology of Legionella pneumonia and factors associated with Legionella-related mortality at a tertiary care center. Clin. Infect. Dis. 1998;27:1479–1486
  34. Waterer GW, Baselski VS, Wunderink RG. Legionella and community-acquired pneumonia: a review of current diagnostic tests from a clinician's viewpoint. Am. J. Med. 2001;110:41–48
  35. Yamamura M, Makimura K, Ota Y. Evaluation of a new rapid molecular diagnostic system for Plasmodium falciparum combined with DNA filter paper, loop-mediated isothermal amplification, and melting curve analysis. Jpn. J. Infect. Dis. 2009;62:20–25

PII: S0732-8893(09)00445-3

doi: 10.1016/j.diagmicrobio.2009.11.001

Diagnostic Microbiology & Infectious Disease
Volume 66, Issue 3 , Pages 253-260 , March 2010